Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-α

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 5, 1998, Pages 463-466

  Kikawa, Yoshiharu ^a   Fukumoto, Yukiko ^a   Obata, Kouichiro ^a   Tamura, Satoshi ^a   Takeuchi, Motohiro ^a   Tanizawa, Akihiko ^a   Mayumi, Mitsufumi ^a  

^a University of Fukui   (Japan)

Author keywords

Agnogenic myeloid metaplasia; Essential thrombocythemia; Idiopathic myelofibrosis; Interferon

Indexed keywords

ALPHA INTERFERON;

ARTICLE; ASTHMA; CASE REPORT; CHILD; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOTHERAPY; MYELOID METAPLASIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTHEMIA; THROMBOCYTOSIS; TREATMENT OUTCOME;

CHILD; FEMALE; HUMANS; INTERFERON-ALPHA; MYELOID METAPLASIA; THROMBOCYTOSIS;

EID: 0032455976     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199809000-00010     Document Type: Article

References (17)

1. Schwartz CL, Cohen HJ. Myeloproliferative and myelodysplastic syndromes. In: Pizzo PA, Poplack DG, (eds). Principles and practice of pediatric oncology. Philadelphia. PA: Lippincott-Raven, 1997:505-21.
2. Boxer LA, Camitta BM, Berenberg W, et al. Myelofibrosis - myeloid metaplasia in childhood. Pediatrics 1975;55:861-5.
3. Cohn SL, Cohn RA, Chou P. et al. Infantile myelofibrosis with nephromegaly secondary to myeloid metaplasia. Clin Pediatr 1991; 30:59-61.
4. Mallouh AA. Sa'di AR. Agnogenic myeloid metaplasia in children. AJDC 1992;146:965-7.
5. Çetingul N, Yener E, Oztop S, et al. Agnogenic myeloid metaplasia in childhood: a report of two cases and efficiency of intravenous high dose methylprednisolone treatment. Acta Paediatr Japon 1994; 36:697-700.
6. Rossbach HC, Grana NH, Chamizo W, et al. Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy. J Pediatr Hematol Oncol 1996;18:213-5.
7. Murphy S, Iland H, Rosenthal D, et al. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:177-82.
8. Thiele J, Zankovich R, Steinberg T, et al. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis-A critical evaluation of clinical and histomorphological data. Acta Haematol 1989;81:192-202.
9. Dalla KP, Zeigler ZR, Shadduck RK. α-interferon in myelofibrosis: a case report. Br J Haematol 1994;86:654-6.
10. Barosi G, Polino G. Chronic myelofibrosis with myeloid metaplasia. The spectrum of clinical syndromes. Hematologica 1987;72: 553-62.
11. Freedman MH, Olivares RS, McClure PD, et al. Primary thrombocythemia in a child. J Pediatr 1973;83:163-1
12. Amato D, Freedman MH. Eleven-year follow-up of "primary thrombocythemia" in a child. J Pediatr 1984;104:639.
13. Sacchi S. The role of a-interferon in essential thrombosythaemia. Polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update. Leuk Lymphoma 1995;19:13-20.
14. Sterkers BY, Preudhomme C, Laï JL. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 1998;91:616-22.
15. Chintagumpala MM, Kennedy LL, Steuber CP. Treatment of thrombocythemia with anagrelide. J Pediatr 1995;127:495-8.
16. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971;50:357-420.
17. Emilia G, Sacchi S, Temperani R, et al. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis. Leuk Lymphoma 1993;9:423-6.